Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Non-Current Assets (2021 - 2025)

PAVmed has reported Other Non-Current Assets over the past 5 years, most recently at $56000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $56000.0 for Q4 2025, down 73.08% from a year ago — trailing twelve months through Dec 2025 was $56000.0 (down 73.08% YoY), and the annual figure for FY2025 was $56000.0, down 73.08%.
  • Other Non-Current Assets for Q4 2025 was $56000.0 at PAVmed, down from $262000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PAVM hit a ceiling of $1.7 million in Q2 2022 and a floor of $56000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $948000.0 (2021), compared with a mean of $818950.0.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 66.67% in 2022 and later tumbled 81.87% in 2024.
  • PAVmed's Other Non-Current Assets stood at $725000.0 in 2021, then surged by 54.62% to $1.1 million in 2022, then grew by 2.32% to $1.1 million in 2023, then tumbled by 81.87% to $208000.0 in 2024, then crashed by 73.08% to $56000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $56000.0 (Q4 2025), $262000.0 (Q3 2025), and $373000.0 (Q2 2025) per Business Quant data.